Clinical trial Recruiting at 1 site Interventional Ages 18 to 64

Evaluating the MIND diet for cognitive improvement in Multiple Sclerosis

Official title: Remote Evaluation of MIND Diet

Run by University of Illinois at Urbana-Champaign · NCT06450977 · Data updated 2026-11-12

This study is testing if following the MIND diet can help people with Multiple Sclerosis improve their memory and thinking skills.

Quick facts

Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity of Illinois at Urbana-Champaign
Academic / other
Locations1 site (Urbana, Illinois)
StatusRecruiting
StartedJune 7, 2024
Main results expectedJanuary 1, 2026
Study endsDecember 31, 2026
Registry record updatedJune 27, 2024
Trial IDNCT06450977 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18-64 with a self-reported diagnosis of Multiple Sclerosis who can consume the provided meals.

Probably not a fit

Patients outside the age range of 18-64, those with other neurodegenerative diseases, or individuals unable to consume the study meals may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine whether adherence to the MIND diet, a dietary pattern designed to enhance brain health, can improve cognitive performance and memory in individuals with Multiple Sclerosis (MS). Participants will receive either a MIND diet meal or a control meal delivered to their homes daily for three months. They will complete online surveys and cognitive assessments before and after the intervention, while also keeping a food diary. The study is conducted entirely remotely, ensuring accessibility for participants.

Why it matters

Potential benefit: If successful, this study could provide a dietary intervention that enhances cognitive function in patients with Multiple Sclerosis.

How similar studies have gone: While dietary interventions for cognitive health have been explored, this specific approach using the MIND diet in MS patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Individuals aged 18-64 years old
2. Self-reported diagnosis of Multiple sclerosis (MS)
3. 20/20 or corrected vision
4. No other neurodegenerative disease diagnosis
5. Stable disease-modifying therapy (DMT) within 6 months
6. Not Pregnant or lactating
7. No food allergies or intolerances
8. Able to consume study meals
9. Not enrolled in another dietary, exercise, or medication study during the study
10. Access to a computer/laptop with internet

Exclusion Criteria:

1. Individuals younger than 18 or older than 64 years old
2. No self-reported diagnosis of Multiple sclerosis (MS)
3. Not 20/20 or uncorrected vision
4. Other neurodegenerative disease diagnosis
5. Disease modifying therapy (DMT) less than 6 months
6. Pregnant or lactating
7. Food allergies or intolerances
8. Not able to consume study meals
9. Enrolled in another dietary, exercise, or medication study during the study
10. No access to a computer/laptop with internet

Where it's running

  • University of Illinois Urbana-Champaign
    Urbana, Illinois, United States
    Recruiting

Study contacts

  • Principal investigator: Naiman Khan, PhD — University of Illinois Urbana-Champaign
  • Study coordinator: Naiman Khan, PhD
  • Email: nakhan2@illinois.edu
  • Phone: 2173001667

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.